Grand Valley State University
Grand Rapids, Michigan, 49504, United States
Location status: Recruiting
NCT Number: NCT07342348
Approximately 40% of children with ambulatory cerebral palsy have significant functional asymmetries in arm and hand function. Children with these significant functional asymmetries have difficulties using their more-affected (less preferred) arm and hand in daily activities, especially true in daily activities requiring bilateral hand and arm use. Recent research suggests that power mobility training provided via a ride-on toy may help to motivate these children to use their less preferred arm and hand. This research further notes that participation in power mobility training designed to encourage a child to use their less preferred arm and hand also may help to improve their arm and hand function and use in their daily activities. This exploratory study seeks to explore an innovative intervention using arm- and hand-use focused power mobility training activities, encompassing both navigational/maneuvering activities and embedded play-based reaching and grasping activities. During power mobility training activities, children will be asked to wear a soft mitten or sock on their preferred hand to help them remember to use their less preferred hand and arm.
The purpose of this exploratory study is to examine both the effect and feasibility of a 6-week laboratory-based arm-and hand-use focused power mobility training program.
Interested in participating?
Request Info3 year–8 year
All sexes
Interventional
Not applicable
Grand Rapids, Michigan, 49504, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
These arm- and hand-use focused power mobility training activities will encompass both navigational/maneuvering activities and play-based reaching and grasping activities embedded into the navigational/maneuvering activities. During power mobility training activities, children will be asked to wear a soft mitten or sock on their preferred hand to help them remember to use their less preferred hand and arm.
Time frame: From enrollment to the end of treatment at 6 weeks
The Canadian Occupational Performance Measure rates parent/caregiver perceptions of their child's performance of 5 arm and hand skills. Each skill is rated from a minimum of 1 to a maximum of 10. A higher score indicates a better outcome. The total score on all 5 items ranges from a minimum of 5 to a maximum of 50. A higher score indicates a better outcome.
Time frame: From enrollment to the end of treatment at 6 weeks
The ABILHAND measures parents' perceptions of their child's manual ability and provides a comprehensive evaluation of the child's functional arm and hand ability. Parents estimate their child's ease or difficulty in performing 17 activities. Each activity is rated using a 3-point Likery scale as follows: 'Impossible=0, Difficult=1, Easy=2. Higher scores indicate a better outcome.
Time frame: From enrollment to the end of treatment at 6 weeks
The Shriner's Hospital Upper Extremity Evaluationis a 16-item video-recorded test to assess spontaneous use and dynamic alignment of the affected UE during bimanual tasks. Higher scores indicate better outcomes.
Time frame: From enrollment to the end of treatment at 8 weeks
Children's grip strength will be measured bilaterally. Higher values indicate a better outcome.
Contact information is provided by the study sponsor or research team.
Grand Valley State University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07433647
Brain Damage, Chronic, Brain Diseases
New York, United States
View Trial DetailsNCT06579027
Brain Damage, Chronic, Brain Diseases
Storrs, Connecticut, United States
View Trial DetailsNCT06314776
Brain Damage, Chronic, Brain Diseases
Almería, Spain
View Trial DetailsNCT03402854
Brain Damage, Chronic, Brain Diseases
White Plains, New York, United States
View Trial Details